- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
NeurogesX Inc+ Add to Watchlist
NGSX:US0.0030 USD 0.0005 14.29%
As of 20:10:00 ET on 12/20/2013.
Company Profile for NeurogesX Inc (NGSX)
NeurogesX, Inc. is a biopharmaceutical company. The Company develops treatments for chronic peripheral neuropathic pain including postherpetic neuralgia, painful HIV-distal sensory polyneuropathy, and painful diabetic neuropathy.
Key Executives for NeurogesX Inc (NGSX)
|Gary A LyonsChairman||Ronald A MartellPresident/CEO|
|Stephen F GhiglieriExec VP/CFO/COO/Secretary||Stephen J PeroutkaExec VP/Chief Medical Officer|
|Michael E MarkelsSenior VP:Commercial||Sara PellegrinoInvestor Relations|